Tarsus Pharmaceuticals, Inc. TARS Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s work in process?
- Tarsus Pharmaceuticals, Inc. (TARS) reported work in process of $1.63M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s work in process changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s work in process increased by 113.6% year-over-year, from $764K to $1.63M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s work in process?
- Over 2 years (2023 to 2025), Tarsus Pharmaceuticals, Inc.'s work in process has grown at a 89.7% compound annual growth rate (CAGR), from $392K to $1.41M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.